2020 American Transplant Congress Archives - Page 24 of 223

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

B Cell Depletion with Anti-CD20 mAb Exacerbates Anti-Donor CD4⁺T Cell Responses in Highly Sensitized Transplant Model

A. Tanaka, K. Ide, Y. Tanaka, M. Ohira, H. Tahara, H. Morimoto, H. Ohdan
B Cell Derived IL-1β and IL-6 Drive Homeostatic T Cell Recovery Following Lymphoablation

S. Hasgur, R. Fan, A. Valujskikh
B₂-Adrenergic Receptor Activation in Donor Cells Inhibits T Cell Trafficking in Vascularized Composite Tissue Allotransplants

M. Kim¹, D. Fisher¹, J. Loo¹, P. Bogner², U. Sharma³, J. Skitzki¹, E. Repasky⁴
Bacterial Infection in Compensated Cirrhosis Predicts Inpatient Mortality and Readmission with Decompensation

R. Rosenblatt¹, A. Jesudian¹, C. Lucero¹, A. Kaplan¹, R. S. Brown¹, V. Sundaram², B. Fortune¹
Bad Actors within Milan Criteria Undergoing OLT- Characterizing Their Pre-Transplant Tumor Behavior and Response to Locoregional Therapy

A. Mathur, E. Baughan, A. Griesemer, M. Najjar, O. Perez, A. Qian, T. Kato, J. Emond
BAFF Inhibition to Prevent Antibody Rebound Following Proteasome Inhibitor-Based Desensitization: A Randomized, Controlled Trial

S. Tremblay¹, A. Rike-Shields², A. Govil¹, M. Cardi³, P. Brailey¹, R. Alloway¹, E. Woodle¹
Bariatric Surgery for Congestive Heart Failure Patients Improves Access to Transplantation and Long-Term Survival

R. A. Choudhury¹, G. Hoeltzel², H. B. Moore¹, H. Yaffe¹, D. Yoeli¹, K. R. Dumon³, K. D. Conzen¹, T. L. Nydam¹
Bariatric Surgery to Achieve Sufficient Weight Loss for Heart Transplant Candidacy: Results of a Systematic Review and Meta-Analysis

B. Orandi¹, J. Purvis¹, S. Mehta¹, M. Gray¹, S. Pamboukian¹, J. Tallaj¹, C. Hoopes¹, C. Lewis¹, N. Terrault², J. Locke¹
Bariatric Surgery to Improve Candidacy for Kidney Transplantation: A Systematic Review and Meta-Analysis

J. Purvis¹, S. Mehta¹, R. Stahl¹, J. Grams¹, M. Hanaway¹, D. Anderson¹, C. Young¹, R. Cannon¹, C. Lewis¹, N. Terrault², J. Locke¹, B. Orandi¹
Bariatric Surgery to Improve Candidacy for Liver Transplantation: A Systematic Review and Meta-Analysis

J. Purvis¹, R. Stahl¹, J. Grams¹, M. Gray¹, D. Eckhoff¹, R. Cannon¹, C. Lewis¹, N. Terrault², J. Locke¹, B. Orandi¹
Barriers for Kidney Transplant Evaluation among People Living with HIV and End-Stage Renal Disease in Mississippi

L. A. Shimose¹, M. X. Bueno Rios¹, J. Clark¹, A. Torres², D. Garcia-Anton², W. Cheungpasitporn², P. Vaitla², F. Cabeza-Rivera²
Barriers to Organ Transplantation among Underrepresented Racial and Ethnic Groups

M. Parra
Basiliximab Induction in the Obese: One Size Does Fit All

A. D. Reticker¹, D. Choi¹, A. B. Lichvar¹, C. Kane², I. Tzvetanov³, E. Benedetti³, J. J. Benken¹
Basiliximab vs Antithymocyte Globulin Induction with Early Steroid Withdrawal in Kidney Transplant Recipients: Early Rejection Outcomes

A. Szczepanik¹, C. Burrelli¹, A. Bixby¹, K. Yadav², K. Chavin²
Because That is Not How The Hierarchy Works: Primary Care Provider Perspectives on Liver Transplant Referral and Access to Transplant

V. Madabhushi¹, A. Murphy², C. Reams³, R. Gedaly³, M. Shah³, N. Pope⁴, M. Gupta⁵
Bedside Ultrasound to Assess for Sarcopenia in Cirrhotic Patients Undergoing Inpatient Liver Transplant Evaluation

M. Aguilar¹, E. A. Rodriguez¹, A. Andrekus², S. Buckner-Petty², N. Dahiya², E. J. Carey²
Belatacept Based Early Steroid Withdrawal Regimens: Differential Responses in African Americans and Non-African Americans

N. Wilson¹, A. R. Shields², A. L. Christianson¹, S. Tremblay¹, D. Kaufman³, A. Wiseman⁴, J. P. Leone⁵, P. West-Thielke⁶, A. J. Matas⁷, R. R. Alloway¹, E. S. Woodle¹
Belatacept Combined with BTLA Prolong Allogeneic Kidney Graft Survival and Inhibited Acute Rejection after Kidney Transplantation

H. Zhang, Z. Wang, J. Zhang, Z. Han, J. Tao, H. Chen, L. Sun, R. Tan, M. Gu
Belatacept Conversion is Safe and Effective in Adolescent and Young Adult Kidney Transplant Recipients

A. Moudgil, C. Petyak, K. Sgambat
Belatacept Conversion: Are Patients BENEFIT-ing

R. Crew, S. Mohan, S. S. Patel
Belatacept Every Two Month Maintenance Dosing in Kidney Transplantation: A Randomized, Non-Inferiority Trial

I. R. Badell, R. Parsons, S. Mead, S. Thomas, G. Karadkhele, S. Pastan, C. Larsen
Belatacept in Kidney Transplant Recipients with Previous Non-Renal Solid Organ Transplants

O. Cristea, C. Larsen, I. Badell
Belatacept Monthly Therapy: Transplant Recipients’ Experience

S. N. Little¹, É. N. Arsenault Knudsen², D. A. Mandelbrot¹
Belatacept Provides Superior Inhibition of Donor Specific Antibody Formation in Kidney Transplant Recipients with Acute Rejection

O. Cristea, C. Larsen, I. Badell
Belatacept Removal by Plasmapheresis: Kinetics, Dose Adjustments and Clinical Recommendations

S. Tremblay¹, N. Wilson¹, B. Miyagawa², H. Kuzaro¹, A. R. Shields³, R. R. Alloway¹, A. Govil¹, J. Kremer⁴, E. Woodle¹, T. Mizuno², A. A. Vinks²
Belatacept Suppresses the B-Cell Alloresponse in the Lower Range of Therapeutic Trough Concentrations

C. Ashokkumar¹, R. Townsend², M. Roberts², T. Lehman², B. Gavin², B. Spishock¹, R. Sindhi¹
Belatacept versus Tacrolimus Combined with Antithymocyte Globulin in Kidney Transplantation

J. Goldman¹, A. Mitrokhin², B. Trivedi¹, V. Vidyasagar¹, N. Vadivel¹, N. Goes³, M. Hart¹
Belatacept-Based Regimens: Induction and Recipient Gender Influence Outcomes

N. Wilson¹, A. R. Shields², A. Wiseman³, A. L. Christianson¹, S. Tremblay¹, D. Kaufman⁴, J. P. Leone⁵, A. J. Matas⁶, P. West-Thielke⁷, R. R. Alloway¹, E. S. Woodle¹
Belatacept-Based, Calcineurin Inhibitor and Corticosteroid Free Immunosuppression: Differential Outcomes Based on Recipient Age

N. Wilson¹, A. R. Shields², D. Kaufman³, A. Wiseman⁴, A. L. Christianson¹, S. Tremblay¹, J. P. Leone⁵, A. J. Matas⁶, P. West-Thielke⁷, R. R. Alloway¹, E. S. Woodle¹
Benefits of Normothermia Regional Perfusion (NRP), Hypothermic Machine Perfusion (HMP) and Short Cold Ischemia Time (CIT) for Kidney Transplants with Controlled Donation after Circulatory Death (cDCD)

E. Savoye¹, C. Legeai¹, J. Branchereau², S. Gay³, S. Drouin⁴, F. Gaudez⁵, B. Veber⁶, J. Venhard⁷, G. Cheisson⁸, T. Kerforne⁹, O. Bastien¹, C. Antoine¹
Benefits of Transplantation Over Chronic Dialysis in Septugenerian ESRD Patients with Diabetes

S. Karhadkar, A. Shaik, A. Di Carlo
Beta Cell Replacement Therapy in Nonuremic Patients with Brittle T1DM Allows for Durable Long Term Insulin Independence Halting Progression of Secondary Diabetic Complications

P. J. Bachul¹, D. J. Grybowski¹, R. Anteby², L. Basto¹, L. Perea¹, K. Golab¹, L. Wang¹, M. Tibudan¹, A. Perez-Gutierrez¹, M. Komorniczak³, A. Lucander¹, P. Borek¹, M. Dimitrov¹, J. Fung¹, P. Witkowski¹
Between-Center Variation in the Survival Benefit of Liver Transplant in the United States

A. Plana¹, S. Paul¹, A. Pillai¹, M. M. Churpek², E. Huang¹, R. Gibbons¹, W. H. Parker¹
Beyond Milan- Not Paying the Price

A. Mathur, C. Brennan, D. Tsapepas, M. Najjar, O. Perez, A. Griesemer, T. Kato, J. Emond
Beyond the Margin: Using Kidneys from Donors on Dialysis

P. S. Patel¹, S. Karir², V. R. Peddi¹, H. Mahanty¹, S. Katznelson¹, J. Bellingham¹, N. Neidlinger¹, A. Hassoun¹, A. Sandhu¹, N. Garg¹, L. Mayen³, W. Bry¹
Bilateral Lung Transplantation Combined with Cardiac Correction in Treatment of Severe Pulmonary Arterial Hypertension Complicated with Eisenmenger Syndrome in Puerpera, a Feasible Strategy for Future?

J. Huang, Z. Wang, J. Chen
Bile Microbiology and Antibiotic Susceptibility in Liver Transplant Recipients versus Non-Transplant Population

S. Suh, Y. Choi
Biliary Reconstructionwith High Biliary Radicals is Safe Option for Multiple Graft Bile Ducts in Right Lobe Living Donor Liver Transplantation

J. Kim, D. Choi, E. Jwa
Biointegration and Function of 3D Printed Bionic Pancreatic Petals on a Mouse Model

M. Wszola¹, M. Klak¹, G. Tymicki¹, A. Berman¹, K. Kosowska¹, T. Bryniarski¹, P. Cywoniuk¹, M. Gomolka¹, P. Kowalska¹, P. Turowski¹, A. Kaminski²
Biomarkers AFP in Combination with AFP-l3 and DCP Predicts Tumor Progression in Treatment Native HCC Patients

K. Nunez, T. Sandow, P. Thevenot, A. Cohen
BK Viremia: A Double Edged Sword – The Impact of Immunosuppression Reduction on Allograft Rejection

A. Szczepanik¹, A. Bixby¹, C. Burrelli¹, A. Padiyar², T. Srinivas², K. Chavin³
BK-Viral Nephropathy after Transplantation of a Non-Renal Organ

A. Schwarz¹, C. Bara², J. Braesen³, J. Gottlieb⁴
Black Patients with Cirrhosis Have Worse Liver-Related Outcomes: A Large Multicenter Study

N. R. Mazumder¹, K. Atiemo², K. Jackson³, A. Daud⁴, A. Kho³, L. G. Gabra⁵, J. Levitsky¹, D. P. Ladner⁴
Blocking Complement Component C3 in a Sensitized Nonhuman Primate Model of Kidney Allotransplantation

R. Schmitz¹, P. M. Schroder¹, Z. W. Fitch¹, A. Y. Choi¹, M. Manook¹, J. Yoon¹, A. Farris², E. S. Reis³, J. D. Lambris³, J. Kwun¹, S. J. Knechtle¹
Bone Marrow Mesenchymal Stem Cells Improve Rat Islet Angiogenesis by Upregulating of ISL1 and VEGF-A

Y. Wang¹, J. Wang², X. Ding²
Bone Marrow Plasma Cell Heterogeneity Drives Resistance of Proteasome Inhibitor Therapy

C. M. Castro-Rojas¹, S. Tremblay², J. Driscoll³, K. Roskin⁴, R. R. Alloway³, E. Woodle², D. A. Hildeman¹
Bortezomib Exhibits Therapeutic Implication in Renal Interstitial Fibrosis after Kidney Transplantation by Inhibiting Akt-mTOR-P70S6K-Smurf2 Pathway and Stabilizing IκBα Protein

C. Suo, Z. Gui, Z. Wang, J. Zhou, M. Zheng, H. Chen, S. Fei, L. Sun, X. Zhang, M. Gu, R. Tan
Bridging the Gap: Normothermic Perfusion of Discarded Livers Significantly Alleviates the Donor Shortage

S. Raigani, R. J. De Vries, C. Carroll, Y. Chen, D. C. Chang, K. Uygun, H. Yeh
Brincidofovir for Adenovirus Disease in Adult Renal Transplant Recipients: A Case Series

F. Zervou¹, I. Zacharioudakis¹, S. A. Mehta², H. J. Neumann²
Brincidofovir for Treatment of Disseminated Human Adenovirus Infection in Pediatric Solid Organ Transplant Recipients

J. Londeree¹, R. Garro¹, R. Romero², R. George¹, P. Winterberg¹, R. Liverman³, A. Serluco³, S. Shin¹, I. Yildirim⁴
Broader Distribution of Kidneys Not Projected to Systematically Favor “Low” Performing OPOs

A. Wilk¹, S. Gustafson², D. Stewart¹, N. Salkowski², D. Zaun², J. Snyder²
Building Kidneys from Stem Cells for Transplantation

I. M. Rogers¹, J. Whiteley², T. Chow², T. Bongolan², L. Mazilescu³, P. Urbanellis³, S. Ganesh³, M. Selzner³
Burnout and Professional Fulfillment among Pediatric Sold Organ Transplant Clinicians Pediatric Transplant

C. Bogle¹, M. K. Cousino Hood², E. M. Fredericks³, J. Magee⁴, S. Warren¹, E. Blume¹
Bypassing the Nearest Transplant Center for Care is Associated with Gains in Time to Living Donor but Not Deceased Donor Kidney Transplantation or Improved Graft Outcomes

A. M. Whelan¹, C. McCulloch², E. Ku¹